New asthma clinical trial: A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma

Published on: March 26, 2019 at 06:00PM
Condition:   Asthma
Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting